[Novel antiarrhythmic class III drug nibentan: from experimental studies to clinical practice].
Rosenshtraukh
L V
LV
Ruda
M Ia
MIa
Golitsyn
S P
SP
Maĭkov
E B
EB
D000328:Adult; D000368:Aged; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001549:Benzamides / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D013610:Tachycardia / Q000188:drug therapy*; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D001549:Benzamides; C105049:nibentan
Novyĭ otechestvennyĭ antiaritmicheskiĭ preparat III klassa nibentan: ot éksperimental'nykh issledovaniĭ k klinicheskoĭ praktike.